Trans-Hit Biomarkers Announces Today a Partnership With Nexelis, Supporting Sample Procurement Activities for a Number of Strategic Projects Including COVID-19 Vaccines and Immuno-oncology Development Initiatives. | Business
LAVAL, Quebec–(BUSINESS WIRE)–Oct 22, 2020– Trans-Hit Biomarkers Inc. (THB) is pleased to announce today the signing of a partnership agreement with Laboratoires Nexelis Canada Inc....

